Period Pills for Menstrual Regulation: A New Reproductive Health Option
University of California, San Francisco · NCT07671989
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · Women only
- Healthy volunteers
- Accepted
- Study type
- Interventional · Phase 4
- Target enrollment
- 100
- US sites recruiting
- 1
- Study start
- June 22, 2026
- Record last updated
- September 2, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The Period Pills Study is a prospective observational study among people who decide to use a combination of mifepristone and misoprostol for menstrual regulation.
Being studied: Mifepristone + Misoprostol
Conditions: Menstrual Regulation; Menstrual Health Intervention
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Be 18 years old or older
- Read and speak English
- Know the date of their last menstrual period within 2 days
- Have a period that is late by up to 21 days
- Must have had regular periods in the last 4 months
- Does not want to be pregnant
- Does not want to verify pregnancy status
- Understand that if they are pregnant, the pills will end their pregnancy
- Does not have contraindications to mifepristone and misoprostol (Risk factors for ectopic pregnancy; history of bleeding disorder or anticoagulant therapy; history of chronic adrenal failure, long-term corticosteroid therapy; allergy to mifepristone/misoprostol/prostaglandins; history of hemorrhagic disorders or anticoagulant therapy; history of inherited porphyrias; has an IUD; currently use a contraceptive implant or injectable)
Exclusion Criteria
- Under 18 years old
- Does not read and speak English
- Does not know the date of their last menstrual period within 2 days
- Has not had regular periods in the last 4 months
- Wants to be pregnant
- Wants to verify pregnancy status
- Does not display understanding that if they are pregnant, the pills will end their pregnancy
- Has any contraindications to mifepristone and misoprostol (Risk factors for ectopic pregnancy; history of bleeding disorder or anticoagulant therapy; history of chronic adrenal failure, long-term corticosteroid therapy; allergy to mifepristone/misoprostol/prostaglandins; history of hemorrhagic disorders or anticoagulant therapy; history of inherited porphyrias; has an IUD; currently use a contraceptive implant or injectable)
Recruiting US locations
Roanoke Health Center
Roanoke, VA 24017
Site contact: Christine Hernández, MPH, MPM, CPHQ · 828-280-5723 · christina.hernandez@ppsat.org
Study contacts (from the official record)
- Ushma D Upadhyay, PhD, MPH · 415-353-4626 · ushma.upadhyay@ucsf.edu
- Jennifer Ko, MLIS · 415-353-9113 · jennifer.ko@ucsf.edu
Similar studies in Virginia
All women’s health studies in Virginia →- RecruitingHealthy volunteersEarly Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
University of Virginia
- Location
- Charlottesville, VA
- Eligibility basics
- Ages 10–17 · Women only
- RecruitingHealthy volunteersEarly Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
University of Virginia
- Location
- Charlottesville, VA
- Eligibility basics
- Ages 10–17 · Women only
- RecruitingHealthy volunteersEarly Phase 1
Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome
University of Virginia
- Location
- Charlottesville, VA
- Eligibility basics
- Ages 18–30 · Women only
- RecruitingHealthy volunteersEarly Phase 1
Does Spironolactone Normalize Sleep-wake Luteinizing Hormone Pulse Frequency in Pubertal Girls With Hyperandrogenism?
University of Virginia
- Location
- Charlottesville, VA
- Eligibility basics
- Ages 10–17 · Women only